GBGiulia Baldazzi

Giulia Baldazzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giulia Baldazzi has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artificial intelligence assessment of the jugular venous pulse from ultrasound high-resolution B-mode clips: A proof of concept

    by Paolo Zamboni, Anselmo Pagani, Giulia Baldazzi, Saverio Farsoni, Pietro Busi, Chiara Marchesin, Antonino Proto, Alessandro Bertagnon


  • Open Access

    Ultrasound Detection of Below-the-Knee Medial Arterial Calcifications in Asymptomatic Patients Is an Early Negative Predictor of Major Adverse Cardiovascular Events

    by Giulia Baldazzi, Nicola Lamberti, Martina Saladini, Maria Cristina Taddia, Valentina Ficarra, Fabio Manfredini, Aaron Thomas Fargion

    Background: Medial arterial calcification (MAC) is a vascular disorder that affects the arterial media layer. It represents a predictor of major adverse limb events in patients affected by diabetes mellitus (DM). This single-center retrospective observational study investigates whether ultrasound (US) detection of MAC in below-the-knee (BTK) vessels represents a negative predictor of major adverse cardiovascular events (MACE) in asymptomatic patients. Methods: In 2019, 584 patients, referred to the Vascular Surgery Unit for lower limb US, were examined by the same operator, who assessed the presence of BTK MAC. The primary outcome was the rate of MACE during a 5-year follow-up period. The secondary outcomes included the development of peripheral arterial disease (PAD), the overall survival rates, lower limb revascularizations, and major amputations. Results: MAC in BTK vessels was highlighted in 239 patients (MAC+) who exhibited a younger age (p < 0.001), DM (p < 0.001), and chronic kidney disease (CKD) (p = 0.048). The 345 subjects without MAC (MAC−) showed prior myocardial infarction (p < 0.001), stroke (p = 0.034), and smoking habits (p < 0.001). After propensity score matching, the MAC+ group presented a higher risk of MACE (HR: 1.84; CI: 1.01–3.38; p = 0.047) during a median follow-up of 57 months. Age (HR: 1.06; CI: 1.01–1.12) and MAC (HR: 1.22; CI: 1.06–1.57) were independently associated with MACE. New diagnoses of PAD mainly occurred in the MAC− group (p < 0.001). No differences were observed in major amputations, revascularization procedures, or overall survival rates. Conclusions: Ultrasound detection of BTK MAC was associated with the presence of DM and CKD and with a 1.8-fold increased risk of developing a MACE within 5 years in asymptomatic patients.

  • Complex Vascular Cases

    by Paolo Zamboni, Giulia Baldazzi, Andrea Ciorba, Stefano Pelucchi

  • Stylo-Carotid Eagle Syndrome

    by Paolo Zamboni, Giulia Baldazzi, Francesco Stomeo, Stefano Pelucchi

  • Jugular Eagle Syndrome

    by Paolo Zamboni, Giulia Baldazzi, Francesco Stomeo, Stefano Pelucchi

  • Open Access

    Mesotherapy versus oral medical treatment of chronic venous insufficiency in a general practitioner setting - A randomized controlled trial

    by Silvia Rossetto, Giulia Baldazzi, Alessandra Gallo, Paolo Zamboni

    Mesotherapy involves the introduction of drugs through dermal microinjections for preventive, therapeutic, or rehabilitative purposes. This study evaluates the safety, tolerability, and effectiveness of mesotherapy in treating Chronic Venous Insufficiency (CVI) compared to traditional oral treatments. Sixty-one patients with CVI (CEAP stage C3-C4) were randomized into two groups. The primary outcome was the measurement of bilateral ankle circumferences. Secondary outcomes included the evaluation of bilateral circumferences and subcutaneous ultrasound thicknesses at the thigh, calf, and medial ankle, and Clinical, Etiological, Anatomical, and Pathophysiological (CEAP) stage variation. The treatment group (30 patients) received mesotherapy with a complex homeopathic product every 15 days for 3 months, and the control group (31 patients) was treated with oral flavonoids for 3 months. With no recorded adverse effects, mesotherapy led to significant reductions in bilateral ankle circumferences (right p=0.0008, left p=0.0075), CEAP stage (p=0.0212), ankle ultrasound thicknesses (right p=0.0037, left p=0.0015) and calf thicknesses (right p=0.0131, left p=0.0137). Mesotherapy was found to be safe, well tolerated, and more effective with respect to oral drugs in CVI patients; however, further randomized, controlled, and blind trials with wider sample sizes are mandatory to confirm our results.

  • Endovascular Exclusion of a Refluxing Segment of Femoral Vein in Post-Thrombotic Syndrome, Characterized by a Vicious Shunt with the Main Upward Draining Pathway

    by Paolo Zamboni, Giulia Baldazzi, Roberto Galeotti

    Purpose: To describe a novel endovascular technique to treat ilio-femoral reflux in post-thrombotic syndrome (PTS). It consists of regulated exclusion of a femoral vein (FV) segment with indication based on Doppler ultrasound (DUS) scan and ascending and descending venogram. Technique: Through lower limb venous DUS, we identify a post-thrombotic refluxing FV, characterized by a duplicated FV and/or ascending collateral veins draining into a common trunk with a re-entry point into the refluxing FV itself. The above findings indicate a second-level venogram. If the descending phase confirms the FV reflux pattern, we perform an ascending venogram to confidently locate where the draining blood is shunted into the FV. We proceed with the scleroembolization of the segment below the shunt. The postoperative venogram documents the treated segment occlusion and the elimination of the reflux. We described 4 cases: 3 successful reflux eliminations and 1 case where we decided not to treat. Mean follow-up lasts 6.5 months with DUS showing the abolition of the reflux; the overall Villalta score, performed at the baseline and last follow-up visit, resulted statistically significant (p = 0.0087). Conclusion: Performing an endovascular regulated exclusion of FV refluxing segment opens a great scenario for PTS treatment; multicenter randomized trials are warranted. Clinical Impact: Recanalized post-thrombotic syndrome, with reflux involving the ilio-popliteal segments, affects the patient’s life without any clear surgical indication. The proposed protocol and technique are based on performing a descending and ascending venogram to identify the point of femoral vein duplication. The regulated exclusion of the refluxing FV segment, below the duplication, by means of scleroembolization, allowed to permanent abolish the reflux. This novel technique is minimally invasive and presents great potential for treating a significant proportion of patients currently managed exclusively with conservative approaches.

  • Current state of education in venous diseases within vascular surgery training programs in Italy: A national web-based survey among residents

    by Daniele Bissacco, Chiara Pisani, Paolo Verlato, Edoardo Forcella, Tiziana Aprea, Giulia Baldazzi, Ailin Belloni, Vanessa Di Mauro, Giuseppe Giuffrè, Marianna Mucignat, et al.

    Background: To analyze the perception of vascular surgery trainees from Italian schools of Vascular Surgery regarding the level of practical and theoretical education in venous diseases. Methods: An anonymous electronic survey was sent to Italian vascular surgery residents affiliated with 19 universities, asking about their training and experience in the management of venous diseases. The survey gathered information on the residents’ personal and demographic details, their university’s teaching program, operative experience in phlebology, as well as their confidence levels in performing various venous procedures, with the goal of analyzing the training and learning programs provided by Italian vascular surgery schools. Results: The analysis showed that 28% of programs do not include phlebology in the curriculum, and more than 40% of residents are unable to independently perform venous duplex ultrasound or treat venous ulcers. Additionally, most residents (over 70%) have limited weekly exposure to phlebology cases, with only 5% having access to a dedicated phlebology operating room. The vast majority of residents (96%) expressed a strong desire to deepen their knowledge and skills in this field, particularly in areas such as endovascular ablation techniques, venous duplex ultrasound, and management of deep venous disease. Conclusions: The survey reveals significant limitations in phlebology education and hands-on experience within the current training programs, highlighting the need to standardize and enhance venous disease management education in order to ensure that future vascular surgeons are adequately equipped to provide high-quality care for patients with a wide range of venous disorders.

  • Open Access

    The sex prevalence of lower limb varicose vein networks

    by Giulia Baldazzi, Mirko Tessari, Matilde Zamboni, Anselmo Pagani, Paolo Zamboni


  • Open Access

    Endovascular Revascularisation versus Open Surgery with Prosthetic Bypass for Femoro-Popliteal Lesions in Patients with Peripheral Arterial Disease

    by Gladiol Zenunaj, Pierfilippo Acciarri, Giulia Baldazzi, Alessio Mario Cosacco, Vincenzo Gasbarro, Luca Traina

    Aim: Complex atherosclerotic femoro-popliteal lesions have traditionally been treated with bypass surgery. A prosthetic graft is used to save the vein graft for more distal revascularisations or when a vein graft is unavailable. The endovascular approach has gained popularity and is offered as a first-line strategy for complex lesions. This study aimed to evaluate whether endovascular procedures can be used as a first-line treatment strategy for complex native femoro-popliteal lesions over open surgery with prosthetic bypass in patients with peripheral arterial disease (PAD). Methods: This single-centre retrospective observational study was conducted between 2013 and 2021; it included patients with symptomatic PAD who required limb revascularisation at the femoro-popliteal segment and who had complex lesions. The primary endpoints analysed were technical success, primary patency, freedom from clinically driven target lesion revascularisation (cdTLR), freedom from major adverse limb and cardiovascular events (MALE and MACE, respectively), freedom from limb loss, and survival. The secondary endpoints were length of in-hospital stay, and duration and costs of the procedure. Results: We identified 185 limbs among 174 suitable candidates for comparison, wherein 105 were treated with an endovascular procedure and 80 with a femoro-popliteal prosthetic bypass. Most patients in both groups presented with chronic limb-threatening ischaemia, and >90% of them had an American Society of Anesthesiologists (ASA) physical status classification of >3. The endovascular group had more octogenarians (p = 0.02) and patients with coronary disease (p = 0.004). The median follow-up was 30 months. The technical failure rate for endovascular procedures was 4.7%, versus 0% in the open group (p = 0.047). Freedom from MACE was similar in both groups. The endovascular group showed superior primary patency (p < 0.0001), cdTLR (p < 0.0001), MALE (p < 0.0001), and freedom from limb loss (p = 0.0018) at 24 and 48 months. Further analysis performed for the open above-the-knee sub-group showed that the aforementioned endpoints were similar between the groups at 12 months and were better in the endovascular group at 24 and 48 months. Procedural time and in-hospital stay were longer in the open group than in the endovascular group (p < 0.0001 and p < 0.001, respectively). The procedural cost in the endovascular group was 10-fold lower than that in the prosthetic bypass group. Conclusions: Endovascular procedures are safe for treating complex femoro-popliteal lesions in patients at a high risk for surgery and show better outcomes at 24 months than prosthetic bypasses do. The latter may be considered as an alternative should endovascular treatment fail.